Inactive Instrument

Press Releases Metsera, Inc.

Stocks

MTSR

US59267L1070

Biotechnology & Medical Research

Press Releases

11-08	Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk	AQ
11-08	Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer	PR
11-06	Metsera Issues Statement in Response to Litigation Ruling	PR
11-04	/C O R R E C T I O N -- Metsera, Inc./	PR
11-03	Metsera Issues Statement in Response to Litigation	PR
01/11/25	Metsera Issues Statement in Response to Litigation	PR
01/11/25	Pfizer sues to stop rival bid for drugmaker Metsera by Denmark's Novo Nordisk	AQ
30/10/25	Metsera Receives Unsolicited Proposal from Novo Nordisk	PR
23/10/25	Metsera Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR	BU
30/09/25	Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3	GL
24/09/25	METSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR	BU
22/09/25	Pfizer amps up push into obesity treatments with $4.9B deal for Metsera	AQ
11/09/25	Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting	GL
28/08/25	Metsera to Present at Upcoming September Investor Conferences	GL
29/07/25	Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress	GL
10/06/25	Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference	GL
09/06/25	Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i	GL
05/06/25	Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®	GL
12/05/25	Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress	GL
09/05/25	Metsera to Present at Bank of America 2025 Global Healthcare Conference	GL
26/03/25	Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress	GL
26/02/25	Metsera to Present at TD Cowen’s 45th Annual Health Care Conference	GL
06/02/25	Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares	AQ